Form 4 for NEOG NEOGEN CORP
Accepted 2024-08-19 00:00:00 ET · period of report 2024-08-15 · accession 0000711377-24-000019 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-08-19 | 2024-08-15 | NEOG | ADENT JOHN EDWARD | CEO | A - Grant | $16.79 | +107.2K | 483.5K | +28% | +$1.80M |
| D | 2024-08-19 | 2024-08-15 | NEOG | ADENT JOHN EDWARD | CEO | A - Grant | $0.00 | +784.6K | 2.13M | +58% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-15 | A | A | 107,207 | $16.79 | 483,514 | D | — | — | (F1) Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants (F2) Includes 4,074 shares held as part of employee stock purchase plan |
| 2 | Derivative | Common Stock (Right to Buy) | 2024-08-15 | A | A | 784,636 | $0.00 | 2,129,279 | D | $16.79 · — to 2031-08-15 | 784,636 Common Stock | (F1) Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants |